(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 147.12% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.67%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Ideaya Biosciences's revenue in 2025 is $7,000,000.On average, 6 Wall Street analysts forecast IDYA's revenue for 2025 to be $10,052,730,784, with the lowest IDYA revenue forecast at $876,436,860, and the highest IDYA revenue forecast at $19,281,610,920. On average, 6 Wall Street analysts forecast IDYA's revenue for 2026 to be $6,710,438,819, with the lowest IDYA revenue forecast at $876,436,860, and the highest IDYA revenue forecast at $14,719,757,064.
In 2027, IDYA is forecast to generate $11,025,312,768 in revenue, with the lowest revenue forecast at $1,971,982,935 and the highest revenue forecast at $18,800,447,084.